GASTROINTESTINAL STROMAL NEOPLASM
Clinical trials for GASTROINTESTINAL STROMAL NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL STROMAL NEOPLASM trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL STROMAL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat GIST: oral combo trial launches
Disease control Recruiting nowThis study tests a new oral drug, ziftomenib, combined with the standard drug imatinib in adults with advanced gastrointestinal stromal tumors (GIST) that no longer respond to imatinib alone. The goal is to see if the combination is safe and can shrink or stabilize tumors. About …
Matched conditions: GASTROINTESTINAL STROMAL NEOPLASM
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated May 17, 2026 03:16 UTC
-
NIH launches Long-Term GIST study to unlock tumor secrets
Knowledge-focused Recruiting nowThis study follows 400 people with gastrointestinal stromal tumors (GISTs) to collect tumor tissue and blood samples for research. Participants are monitored every 6-12 months for up to 10 years before surgery, and then for 5 years after. The goal is to better understand the dise…
Matched conditions: GASTROINTESTINAL STROMAL NEOPLASM
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC